(+) Flex Pharma ( FLKS ), which was surging more than 38% off a trading halt. The company said it has agreed to merge with privately held cancer drug developer Salarius.
(+) Novavax ( NVAX ) was up more than 7% after reporting “positive” results from its mid-stage clinical trial of NanoFlu.
(+) Esperion Therapeutics ( ESPR ) was slightly higher after unveiling a licensing agreement to provide Daiichi Sankyo Europe with exclusive rights to commercialize bempedoic acid and the bempedoic acid/ezetimibe combination pill in the European Economic Area and Switzerland.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.